5245 spółek pasuje
Showing 4551–4600 of 5245
| Spółka | Ocena | Cena | Od szczytu | C/Z | Wielkość | Stopa | Opcje | Branża |
|---|---|---|---|---|---|---|---|---|
| B | 18,01 USD | -36% | — | 19,9M USD | — | — | Biotechnology | |
| ELWTElauwit Connection, Inc. | F- | 3,00 USD | -66% | — | 19,9M USD | — | — | Telecom Services |
| D | 7,21 USD | -26% | — | 19,6M USD | — | — | Software Application | |
| B- | 0,53 USD | -84% | — | 19,5M USD | — | Miesięczne | Resorts and Casinos | |
| D+ | 9,53 USD | -37% | 12,70 | 19,5M USD | 1,0% | — | Oil Gas E and P | |
| C | 1,79 USD | -38% | — | 19,5M USD | — | — | Drug Manufacturers Specialty and Generic | |
| C- | 0,96 USD | -97% | — | 19,5M USD | — | — | Packaged Foods | |
| Bez oceny | 1,95 USD | -86% | — | 19,4M USD | — | Miesięczne | Biotechnology | |
| C | 2,35 USD | -22% | — | 19,4M USD | — | — | Semiconductors | |
| B | 2,19 USD | -53% | — | 19,4M USD | — | Miesięczne | Biotechnology | |
| Bez oceny | 1,01 USD | -36% | — | 19,4M USD | — | — | Biotechnology | |
| F- | 1,26 USD | -65% | — | 19,3M USD | — | — | Capital Markets | |
| F- | 0,35 USD | -89% | — | 19,3M USD | — | Miesięczne | Capital Markets | |
| C | 1,05 USD | -92% | — | 19,1M USD | — | Miesięczne | Solar | |
| D- | 1,72 USD | -85% | — | 19M USD | — | — | Biotechnology | |
| F | 11,62 USD | -16% | 3,03 | 18,9M USD | 2,3% | — | Real Estate Services | |
| F | 1,36 USD | -94% | — | 18,8M USD | — | — | Medical Devices | |
| F- | 1,05 USD | -78% | — | 18,7M USD | — | — | Biotechnology | |
| C | 2,29 USD | -15% | 38,08 | 18,7M USD | — | — | Specialty Retail | |
| D | 1,29 USD | -38% | 6,60 | 18,7M USD | — | — | Specialty Retail | |
| Bez oceny | 1,94 USD | -89% | — | 18,7M USD | — | — | Biotechnology | |
| F- | 0,98 USD | -99% | — | 18,7M USD | — | — | Restaurants | |
| F | 2,71 USD | -66% | — | 18,7M USD | — | — | Industrial Distribution | |
| F- | 0,78 USD | -82% | — | 18,6M USD | — | Miesięczne | Capital Markets | |
| D | 2,55 USD | -85% | — | 18,5M USD | — | — | Medical Care Facilities | |
| Bez oceny | 19,34 USD | -43% | — | 18,3M USD | — | Miesięczne | — | |
| F | 5,80 USD | -49% | 1,18 | 18,3M USD | — | — | Real Estate Services | |
| F- | 0,51 USD | -61% | — | 18,1M USD | — | — | Education and Training Services | |
| C | 1,38 USD | -39% | — | 17,8M USD | — | — | Internet Content and Information | |
| F- | 1,94 USD | -41% | — | 17,8M USD | — | — | Communication Equipment | |
| C | 1,21 USD | -100% | — | 17,7M USD | — | — | Medical Devices | |
| D- | 0,99 USD | -100% | — | 17,5M USD | — | — | Engineering and Construction | |
| C- | 1,09 USD | -90% | — | 17,4M USD | — | — | Engineering and Construction | |
| F | 0,38 USD | -73% | — | 17,3M USD | — | — | Drug Manufacturers Specialty and Generic | |
| Bez oceny | 0,52 USD | -65% | — | 17,3M USD | — | — | Biotechnology | |
| D- | 0,60 USD | -94% | — | 17,2M USD | — | Miesięczne | Medical Devices | |
| F | 1,32 USD | -38% | — | 17,1M USD | — | — | Engineering and Construction | |
| Bez oceny | 0,19 USD | -94% | — | 17,1M USD | — | — | Biotechnology | |
| F- | 3,00 USD | -98% | — | 17M USD | — | — | Telecom Services | |
| F- | 3,79 USD | -59% | — | 17M USD | — | — | Software Application | |
| F | 2,98 USD | -75% | — | 16,9M USD | — | — | Capital Markets | |
| F | 1,92 USD | -35% | — | 16,8M USD | — | — | Internet Retail | |
| A | 4,48 USD | -38% | 5,59 | 16,8M USD | — | — | Apparel Manufacturing | |
| D- | 8,41 USD | -97% | — | 16,7M USD | — | — | Building Products and Equipment | |
| F | 0,73 USD | -52% | — | 16,6M USD | — | — | Software Infrastructure | |
| Bez oceny | 2,03 USD | -87% | — | 16,5M USD | — | — | Medical Devices | |
| F- | 0,55 USD | -35% | — | 16,5M USD | — | Miesięczne | Medical Instruments and Supplies | |
| D | 0,64 USD | -75% | — | 16,4M USD | — | Miesięczne | Gambling | |
| Bez oceny | 0,81 USD | -76% | — | 16,4M USD | — | — | Uranium | |
| C- | 2,40 USD | -73% | — | 16,3M USD | — | — | Pollution and Treatment Controls |
Filtr to nie rekomendacja. Każdy wiersz spełnił podany warunek i nic ponadto — InspectStocks opisuje spółki na podstawie ich własnych raportów do SEC i nie doradza kupna ani sprzedaży.